Money Matters
-
Forward Look
Here Come the BiosimilarsAs patents expire on biologic drugs, cancer patients get new options.
by Stephen Ornes
-
Survivor Profile
Sharing Her StrengthDiagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.
by Lindsey Konkel
-
Parking Costs Take a Hidden Toll on Cancer PatientsPeople with cancer can pay significant costs for parking at cancer centers while receiving their treatment, a study finds.
by Marcus A. Banks
-
Using Leftover Cancer Drugs to Help OthersCancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.
by Jon Kelvey
-
Forward Look
Getting Help to Avoid Financial DistressTodd Yezefski on financial navigators.
by Sue Rochman
-
Despite Generic Imatinib, Cost of Treating CML Remains HighThe arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.
by Anna Azvolinsky
-
Clinical Trials: An African American Survivor’s ExperienceMelvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
-
Food Insecurity and CancerAfter discovering that some patients weren't able to access the food they needed, a community oncology practice partnered with a local food bank.
by Jen Tota McGivney
-
Caregiving With Confidence
Take Financial InventoryTreatment-related expenses can increase stress on both caregivers and patients. Learning to talk about these concerns may help ease the burden.
by Aimee Swartz
-
Forward Look
Medicare to Cover CAR-T Cell TherapyHigh cost may still limit access.
by Nancy Averett
